Intraperitoneal (IP) administration of the acetylcholinesterase inhibitor, soman (10-40 micrograms/kg), suppressed in a dose-related manner response rates in rats maintained under a multiple fixed-interval 50-s fixed-ratio 25 schedule of food delivery. Chronic administration of soman at weekly intervals resulted in tolerance to the response. When soman administration was separated by 2-5 weeks in individual rats, the suppressive effects of the agent again became apparent. Analysis of acetylcholinesterase activity revealed that enzyme inhibition was limited to gastrointestinal areas near the site of injection. There was no significant effect on brain acetylcholinesterase even following IP injection of doses which completely suppressed responding. The IP route may be useful for studying tolerance and other chronic effects of soman without producing generalized toxicity.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF00427899DOI Listing

Publication Analysis

Top Keywords

soman
5
repeated intraperitoneal
4
intraperitoneal injections
4
injections soman
4
soman schedule-controlled
4
schedule-controlled behavior
4
behavior rat
4
rat intraperitoneal
4
intraperitoneal administration
4
administration acetylcholinesterase
4

Similar Publications

Prophylaxis by a reversible cholinesterase inhibitor and the treatment NMDA receptor antagonists as combinatorial countermeasure against nerve agent poisoning in mice model.

Chem Biol Interact

January 2025

Department of Toxicology and Military Pharmacy, Military Faculty of Medicine, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic. Electronic address:

The current pharmacological pretreatment and medical treatment of nerve agent poisoning is an insufficiently addressed medical task. The prophylactic efficacy of a novel compound acting dually as an acetylcholinesterase inhibitor and NMDA receptor antagonist (K1959) and the therapeutic efficacy of a novel NMDA receptor antagonist (K2060) were evaluated in the NMRI mice model of nerve agent poisoning by tabun, soman and sarin. Their added value to the standard antidotal treatment (a combination of oxime reactivator and atropine) was also analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the effectiveness of antimicrobial photodynamic therapy (aPDT) combined with mechanical debridement (MD) in treating peri-implantitis in patients undergoing chemotherapy compared to systemically healthy patients.
  • Both patient groups were assessed; however, results showed no significant differences in key measurements (plaque and gingival indices, probing depth, and bone loss) between the two groups at both baseline and three-month follow-up.
  • Overall, the findings indicated that adding aPDT to MD did not lead to enhanced treatment outcomes for peri-implantitis in either chemotherapy patients or systemically healthy individuals.
View Article and Find Full Text PDF

Organophosphorus (OP) pesticides (e.g., parathion) and nerve agents (e.

View Article and Find Full Text PDF

Introduction: Pregestational diabetes mellitus (PGDM) occurs when a woman becomes pregnant after having diabetes mellitus. The presence of diabetes during the entire pregnancy can have an adverse impact on fetal and neonatal outcomes. The objective of this study is to examine the association between PGDM and neonatal outcomes at birth.

View Article and Find Full Text PDF

Background: Stroke is a leading cause of global mortality and disability, with a disproportionately high burden in low- and middle-income countries. Access to intravenous thrombolysis (IVT) and endovascular treatment (EVT) remains extremely limited.

Aims: We evaluated the spatial distribution and geographic accessibility of stroke centers in India.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!